Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Illumina for Startups Home

The $1,000 Genome

Staggering reduction in cost will help revolutionize medicine

The $1,000 Genome
10 August 2015

Download the PDF »

Previous Article
Next Article

Recent Articles

Inspiring young minds: HRH The Princess Royal helps Illumina celebrate DNA Day
Inspiring young minds: HRH The Princess Royal helps Illumina celebrate DNA Day
Engineering a cool career in biotech—and volunteering along the way
Engineering a cool career in biotech—and volunteering along the way
Evidence supports sequencing as first-line rare disease diagnostic
Evidence supports sequencing as first-line rare disease diagnostic
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.